Could a common mineral cut opioid use after prostate surgery?

NCT ID NCT06477133

Ongoing Symptom relief Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether giving magnesium sulfate during prostate surgery can lower pain and reduce the need for strong painkillers. About 68 adults having robotic prostate surgery will either receive magnesium or not, as part of their standard anesthesia. Researchers will compare pain scores and opioid use between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: magnesium sulfate
What this could lead to: If it works, this could offer a simple, safe way to reduce pain and opioid use after prostate surgery.
What could go wrong: This is a small, single-center trial with only 68 participants. The results may not apply to all patients or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATECTOMY

Contacts and locations

Show contact details

Locations

NYU Langone Health

New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.